Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06460181 · ClinicalTrials.gov registry record · Phase 4
Impact of Astaxanthin on Cognition in Recreationally Active Females
A Phase 4 study of Mental Fatigue, sponsored by University of North Alabama.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06460181 is a Phase 4 study of Mental Fatigue that is actively recruiting participants, run by University of North Alabama. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06460181, a Phase 4 study of Mental Fatigue, is actively recruiting participants, sponsored by University of North Alabama.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the protentional that the antioxidant Astaxanthin has on mitigating cognitive decline following mental fatigue.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Astaxanthin
- DIETARY_SUPPLEMENT Placebo
Study Locations (1)
Alabama
- University of North Alabama - Florence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2024-11-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06460181
The ClinicalTrials.gov registry entry for NCT06460181 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Alabama, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mental Fatigue appearing as the primary indexed condition, and to 2 interventions - of which Astaxanthin is the first listed.
NCT06460181 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT06460181 about?
NCT06460181 is a clinical study titled "Impact of Astaxanthin on Cognition in Recreationally Active Females". The purpose of this study is to examine the protentional that the antioxidant Astaxanthin has on mitigating cognitive decline following mental fatigue.
What is the current status of trial NCT06460181?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2024-08-01. Estimated completion is 2024-11-01.
What conditions does trial NCT06460181 study?
This clinical trial studies the following conditions: Mental Fatigue.
What interventions are being tested in trial NCT06460181?
The interventions under investigation include: Astaxanthin (DIETARY_SUPPLEMENT), Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06460181?
This trial is sponsored by University of North Alabama, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06460181 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mental Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.